These results were qualitatively in accord with the higher expression levels of ST3GAL4 compared to ST3GAL3 described in pancreatic adenocarcinoma tissues, where ST3GAL4 and ST3GAL3 levels were higher than the mean of pancreatic control tissue by about 4-fold and 2-fold, respectively [10]. The gene discussed is ST3GAL4; the disease is pancreatic adenocarcinoma.